Published in Neuropsychopharmacology on April 01, 2006
N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol (2007) 4.63
1H-MRS at 4 tesla in minimally treated early schizophrenia. Mol Psychiatry (2009) 1.40
Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol Psychiatry (2007) 1.12
Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. Neuropsychopharmacology (2013) 0.92
Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate. A spectroscopic test-retest study in adult ADHD. Eur Arch Psychiatry Clin Neurosci (2008) 0.91
Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update. Dialogues Clin Neurosci (2013) 0.90
Long term antipsychotic treatment does not alter metabolite concentrations in rat striatum: an in vivo magnetic resonance spectroscopy study. Schizophr Res (2011) 0.80
Medial-frontal cortex hypometabolism in chronic phencyclidine exposed rats assessed by high resolution magic angle spin 11.7 T proton magnetic resonance spectroscopy. Neurochem Int (2012) 0.80
Region-specific alteration in brain glutamate: possible relationship to risk-taking behavior. Physiol Behav (2009) 0.78
Time-dependent effects of haloperidol on glutamine and GABA homeostasis and astrocyte activity in the rat brain. Psychopharmacology (Berl) (2013) 0.78
Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A (1)H-MRS and pCASL study. Neuropsychopharmacology (2016) 0.77
The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study. Neuropsychiatr Dis Treat (2014) 0.75
Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study. Transl Psychiatry (2016) 0.75
Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7Tesla. Schizophr Res (2016) 0.75
Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal (1)H-MRS Studies. Front Psychiatry (2017) 0.75
Antigliadin Antibodies (AGA IgG) Are Related to Neurochemistry in Schizophrenia. Front Psychiatry (2017) 0.75
Neural substrates for voluntary suppression of negative affect: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 4.84
Test-retest and between-site reliability in a multicenter fMRI study. Hum Brain Mapp (2008) 2.63
A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr Bull (2008) 2.35
Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA (2003) 2.30
Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study. Hum Brain Mapp (2009) 2.28
Real-time fMRI of temporolimbic regions detects amygdala activation during single-trial self-induced sadness. Neuroimage (2003) 2.09
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry (2005) 1.84
Role of HuD and other RNA-binding proteins in neural development and plasticity. J Neurosci Res (2002) 1.76
Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS. J Neurol Sci (2010) 1.60
Getting actionable about community resilience: the Los Angeles County Community Disaster Resilience project. Am J Public Health (2013) 1.59
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum Mol Genet (2011) 1.52
Medial temporal N-acetyl-aspartate in pediatric major depression. Psychiatry Res (2008) 1.44
Voxel-based morphometric multisite collaborative study on schizophrenia. Schizophr Bull (2008) 1.43
Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry (2004) 1.41
Patient and psychiatrist ratings of hypothetical schizophrenia research protocols: assessment of harm potential and factors influencing participation decisions. Am J Psychiatry (2002) 1.41
Tuning in to the voices: a multisite FMRI study of auditory hallucinations. Schizophr Bull (2008) 1.38
Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry (2004) 1.35
A Review of Challenges in the Use of fMRI for Disease Classification / Characterization and A Projection Pursuit Application from Multi-site fMRI Schizophrenia Study. Brain Imaging Behav (2008) 1.33
The RNA-binding protein HuD: a regulator of neuronal differentiation, maintenance and plasticity. Bioessays (2006) 1.33
Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study. Neoplasia (2011) 1.29
Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse (2002) 1.27
Increased amygdala: hippocampal volume ratios associated with severity of anxiety in pediatric major depression. J Child Adolesc Psychopharmacol (2003) 1.26
Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study. Schizophr Bull (2009) 1.25
Amygdala and hippocampal volumes in familial early onset major depressive disorder. Biol Psychiatry (2007) 1.25
Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function. Neurobiol Dis (2007) 1.24
Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia. Neuropsychopharmacology (2009) 1.20
Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings. Neuropsychopharmacology (2004) 1.20
Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biol Psychiatry (2005) 1.20
Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg (2011) 1.19
The MCIC collection: a shared repository of multi-modal, multi-site brain image data from a clinical investigation of schizophrenia. Neuroinformatics (2013) 1.14
Lasers in the treatment of nonmelanoma skin cancer. Dermatol Surg (2011) 1.11
Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology (2005) 1.11
Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia. Neuropsychopharmacology (2007) 1.10
Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla. Biol Psychiatry (2010) 1.10
Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome. Genome Biol (2012) 1.09
Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. J Am Acad Child Adolesc Psychiatry (2004) 1.07
Applying community engagement to disaster planning: developing the vision and design for the Los Angeles County Community Disaster Resilience initiative. Am J Public Health (2013) 1.06
Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia. J Clin Psychopharmacol (2008) 1.04
Identification of genetic and epigenetic marks involved in population structure. PLoS One (2010) 1.04
Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders. Psychopharmacol Bull (2002) 1.04
Magnetic resonance and spectroscopic imaging in prenatal alcohol-exposed children: preliminary findings in the caudate nucleus. Neurotoxicol Teratol (2006) 1.04
Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla. Neuroreport (2005) 1.03
Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study. Neurosurgery (2006) 1.03
Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biol Psychiatry (2003) 1.03
Brain-performance correlates of working memory retrieval in schizophrenia: a cognitive modeling approach. Schizophr Bull (2008) 1.02
Real-time fMRI of cortico-limbic brain activity during emotional processing. Neuroreport (2004) 1.02
Neural correlates of internally-generated disgust via autobiographical recall: a functional magnetic resonance imaging investigation. Neurosci Lett (2004) 0.99
Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biol Psychiatry (2002) 0.99
Acute depletion of reduced glutathione causes extensive carbonylation of rat brain proteins. J Neurosci Res (2006) 0.98
Prefrontal cortical volume in childhood-onset major depression: preliminary findings. Arch Gen Psychiatry (2002) 0.98
Guided exploration of genomic risk for gray matter abnormalities in schizophrenia using parallel independent component analysis with reference. Neuroimage (2013) 0.98
Genetic associations of brain structural networks in schizophrenia: a preliminary study. Biol Psychiatry (2010) 0.97
Single prolonged stress decreases glutamate, glutamine, and creatine concentrations in the rat medial prefrontal cortex. Neurosci Lett (2010) 0.96
Repeated unpredictable stress and antidepressants differentially regulate expression of the bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology (2007) 0.96
Potential Impact of miR-137 and Its Targets in Schizophrenia. Front Genet (2013) 0.96
Efficacy of an accelerated hepatitis B vaccination program during pregnancy. Obstet Gynecol (2011) 0.96
High mortality in patients with chronic wounds. Wound Repair Regen (2011) 0.94
Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy. J Am Acad Child Adolesc Psychiatry (2003) 0.94
Biochemical correlates of neuropsychiatric illness in maple syrup urine disease. J Clin Invest (2013) 0.93
Source-based morphometry analysis of group differences in fractional anisotropy in schizophrenia. Brain Connect (2011) 0.93
Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion. Toxicol Sci (2012) 0.92
Neurochemical, hormonal, and behavioral effects of chronic unpredictable stress in the rat. Behav Brain Res (2011) 0.91
Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder. J Child Adolesc Psychopharmacol (2003) 0.91
High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia. Am J Psychiatry (2002) 0.91
Blast-induced neurotrauma leads to neurochemical changes and neuronal degeneration in the rat hippocampus. NMR Biomed (2012) 0.90
Neuropsychological testing and structural magnetic resonance imaging as diagnostic biomarkers early in the course of schizophrenia and related psychoses. Neuroinformatics (2011) 0.89
Increased expression of axogenesis-related genes and mossy fibre length in dentate granule cells from adult HuD overexpressor mice. ASN Neuro (2011) 0.89
The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders. J Clin Psychiatry (2003) 0.88
A pilot study on collective effects of 22q13.31 deletions on gray matter concentration in schizophrenia. PLoS One (2012) 0.88
A review of evidence for safe abortion care. Contraception (2012) 0.88
Cigarette smoking and white matter microstructure in schizophrenia. Psychiatry Res (2012) 0.88
Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat. NMR Biomed (2009) 0.87
The RNA-binding protein HuR binds to acetylcholinesterase transcripts and regulates their expression in differentiating skeletal muscle cells. J Biol Chem (2005) 0.86
Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure. Schizophr Res (2002) 0.86
Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine. Neurochem Int (2009) 0.86
Treatment of weight gain with fluoxetine in olanzapine-treated schizophrenic outpatients. Neuropsychopharmacology (2002) 0.85
Development and sexual dimorphism of the pituitary gland. Life Sci (2006) 0.85
MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain. Neurotoxicology (2010) 0.85
Alterations in mossy fiber physiology and GAP-43 expression and function in transgenic mice overexpressing HuD. Hippocampus (2008) 0.85
State of the art in topical wound-healing products. Plast Reconstr Surg (2011) 0.85
An ICA with reference approach in identification of genetic variation and associated brain networks. Front Hum Neurosci (2012) 0.85
Integrated treatment of schizophrenia. Psychiatr Serv (2003) 0.85
Post-transcriptional regulation of acetylcholinesterase mRNAs in nerve growth factor-treated PC12 cells by the RNA-binding protein HuD. J Biol Chem (2002) 0.85
Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels. Schizophr Res (2004) 0.84
Reproducibility of 1H-MRS measurements in schizophrenic patients. Magn Reson Med (2003) 0.84
Proton echo-planar spectroscopic imaging with highly effective outer volume suppression using combined presaturation and spatially selective echo dephasing. Magn Reson Med (2003) 0.84
The RNA-binding protein HuD binds acetylcholinesterase mRNA in neurons and regulates its expression after axotomy. J Neurosci (2007) 0.83
Pituitary volume in treatment-naïve pediatric major depressive disorder. Biol Psychiatry (2006) 0.83
Single prolonged stress enhances hippocampal glucocorticoid receptor and phosphorylated protein kinase B levels. Neurosci Res (2012) 0.83
Pituitary volume in pediatric obsessive-compulsive disorder. Biol Psychiatry (2005) 0.83
Neonatal alcohol-induced region-dependent changes in rat brain neurochemistry measured by high-resolution magnetic resonance spectroscopy. Alcohol Clin Exp Res (2008) 0.83
Engaging parents in evidence-based treatments in schools: Community perspectives from implementing CBITS. School Ment Health (2013) 0.82
Spinal subdural hemorrhage in abusive head trauma: a retrospective study. Radiology (2011) 0.82